Alopecia Areata Treatment Advancements and Emerging Technology
How the 2024 Election Will Determine the Future of America's Health Crises
Patients With MDS Disagree With Physicians About Symptom Frequency
New Work Highlights Proteins as Potential Novel AML Therapeutic Targets
Review Emphasizes Potential Infection Risks With BTK Inhibitors
Health Equity & Access Weekly Roundup: November 2, 2024
5 Essential Drugs Currently Facing Shortages
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
Bird Flu Cases Spark More Preventive Measures to Curb Spread
COVID-19 Leaves Lasting Impact on Nursing Practices and Job Satisfaction
Dr Sanjula Jain: US Health Care Spending “Defies Laws of Economics”
Early Smoking Cessation Treatment After Cancer Diagnosis Improves Survival
Canada Less Likely to Have Meaningful Drug Shortages Due to Supply Chain Issues
Employers Shift to Equity-Focused Strategies as Health Costs Outpace Wages
Alopecia Areata Risk in Patients With IBD Tied to Anti-TNF Use
Contributor: Vulnerable Seniors Are at Risk With Looming Medicare Advantage Cuts—Income-Based Programs Can Minimize the Damage
With Hidradenitis Suppurativa, Maternal and Offspring Outcomes May Suffer
ACA Enrollees Share Mixed Opinions Ahead of Open Enrollment, Upcoming Election
High Health Care Burden of Transfusion-Dependent β-Thalassemia
Low Pulmonary Rehabilitation, Palliative Care Referrals for Patients With IPF Persist
New AI Tool Identifies Undiagnosed PNH in Health Records
Improving Early-Stage Lung Cancer Care
Zanubrutinib More Effective Than Ibrutinib in Treating Patients With Relapsed/Refractory CLL, SLL
Higher TMB, PD-L1 Expression Correlate With Shorter Survival in Hematologic Malignancies
Medicare Shared Savings Program Continues to Deliver Savings, Quality Care
Pediatric Alopecia Areata Risks and Disparities Vary by Race and Ethnicity
Biosimilar Aflibercept P041 as Effective, Safe as Originator in nAMD
After HMA Resistance in AML, a New Possible Therapy Option
Exploring the Complexities of Biosimilars and Interchangeability
Prednisone Superior to Other Corticosteroids for Patients With COPD, Heart Failure